NDC 58517-240

Losartan Potatssium

Losartan Potatssium

Losartan Potatssium is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by New Horizon Rx Group, Llc. The primary component is Losartan Potassium.

• Product ID: 58517-240_3457501e-f3b7-48df-a874-ab25db0a4797
• NDC: 58517-240
• Product Type: Human Prescription Drug
• Proprietary Name: Losartan Potatssium
• Generic Name: Losartan Potatssium
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2013-08-25
• Marketing Category: ANDA / ANDA
• Application Number: ANDA078243
• Labeler Name: New Horizon Rx Group, LLC
• Substance Name: LOSARTAN POTASSIUM
• Active Ingredient Strength: 50 mg/1
• Pharm Classes: Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 58517-240-30

30 TABLET in 1 BOTTLE (58517-240-30)

• Marketing Start Date: 2013-08-25
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 58517-240-30 [58517024030]

Losartan Potatssium TABLET

• Marketing Category: ANDA
• Application Number: ANDA078243
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2013-08-25
• Inactivation Date: 2019-11-27

Drug Details

Active Ingredients

Ingredient	Strength
LOSARTAN POTASSIUM	50 mg/1

OpenFDA Data

• SPL SET ID: 4ef177d5-647b-4810-ad56-a3905f09e3f7
• Manufacturer:
  • New Horizon Rx Group, LLC
• UNII:
  • 3ST302B24A
• RxNorm Concept Unique ID - RxCUI:
  • 979492
• UPC Code:
  • 0358517240304

Pharmacological Class

• Angiotensin 2 Receptor Antagonists [MoA]
• Angiotensin 2 Receptor Blocker [EPC]

Medicade Reported Pricing

58517024030 LOSARTAN POTASSIUM 50 MG TAB

Pricing Unit: EA | Drug Type: